Figure 2.
(A) Percentage changes of CD44+, ESA+ cells by FACS analysis 96 h after carbon ion beam, X-ray, 10 nM gemcitabine (GEM) alone or in combination with 10 nM gemcitabine in PANC1 cells. (B) Percentage changes of double CD44+/ESA+ cells by FACS analysis 72h after carbon ion beam, X-ray10 nM gemcitabine alone or in combination with 10 nM gemcitabine in PK45 cells.